Predictive Oncology is a healthcare company that provides personalized medicine solution and medical devices in two areas: precision medicine, which aims to apply artificial intelligence to personalized medicine and drug discovery; and an environmentally safe system for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. Co.'s segments are domestic, international, and Helomics. Domestic and international consist of the STREAMWAY System, which eliminates staff exposure to blood, irrigation fluid and other infectious fluids found in the healthcare environment. The Helomics segment consists of clinical testing and contract research. The POAI stock yearly return is shown above.
The yearly return on the POAI stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2016 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the POAI annual return calculation with any dividends reinvested as applicable (on ex-dates).
|